Society for Immunotherapy of Cancer; TILs: Tumor infiltrating T lymphocytes; TECs: Tumor endothelial cells ,
Fas-ligand; IL-10: Interleukin-10; TGF-?: Transforming growth factor-beta ,
Immune infiltration in human tumors: a prognostic factor that should not be ignored, Oncogene, vol.173, issue.8, pp.1093-1102, 2010. ,
DOI : 10.1038/nrc1586
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma, Cancer, vol.77, issue.7, pp.1303-1310, 1996. ,
DOI : 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas, Cancer Res, vol.61, pp.3932-3936, 2001. ,
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer, New England Journal of Medicine, vol.348, issue.3, pp.203-213, 2003. ,
DOI : 10.1056/NEJMoa020177
CD8 + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer, Cancer Res, vol.58, pp.3491-3494, 1998. ,
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy, Nature Medicine, vol.32, issue.1, pp.28-36, 2008. ,
DOI : 10.1182/blood-2004-05-1906
Creating immune privilege: active local suppression that benefits friends, but protects foes, Nature Reviews Immunology, vol.176, issue.1, pp.74-80, 2008. ,
DOI : 10.1038/nri2233
Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells, Cancer Immunology, vol.5, pp.8-12, 2005. ,
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells, The Journal of Experimental Medicine, vol.9, issue.1, pp.49-55, 2007. ,
DOI : 10.1073/pnas.111161198
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase, Journal of Clinical Investigation, vol.117, issue.9, pp.2570-2582, 2007. ,
DOI : 10.1172/JCI31911DS1
Blocking IDO activity to enhance anti-tumor immunity, Frontiers in Bioscience, vol.4, issue.2, pp.734-745, 2012. ,
DOI : 10.2741/e414
GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase, Immunity, vol.22, issue.5, pp.633-642, 2005. ,
DOI : 10.1016/j.immuni.2005.03.013
Indoleamine 2,3 dioxygenase and metabolic control of immune responses, Trends in Immunology, vol.34, issue.3, pp.137-143, 2012. ,
DOI : 10.1016/j.it.2012.10.001
Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen, Cell Reports, vol.2, issue.3, pp.628-639, 2012. ,
DOI : 10.1016/j.celrep.2012.08.006
Gene Signature in Melanoma Associated With Clinical Activity, The Cancer Journal, vol.16, issue.4, pp.399-403, 2010. ,
DOI : 10.1097/PPO.0b013e3181eacbd8
dendritic cells, The Journal of Experimental Medicine, vol.61, issue.10, pp.2005-2016, 2011. ,
DOI : 10.1158/0008-5472.CAN-07-5324
Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo, The Journal of Experimental Medicine, vol.162, issue.12, pp.2157-2163, 2012. ,
DOI : 10.1111/j.1600-065X.2008.00647.x
Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases, Cancer Research, vol.72, issue.16, pp.4997-5002, 2012. ,
DOI : 10.1158/0008-5472.CAN-12-1377
T cell concentration determines their efficiency in killing cognate antigen???expressing syngeneic mammalian cells in vitro and in mouse tissues, The Journal of Experimental Medicine, vol.46, issue.1, pp.223-235, 2010. ,
DOI : 10.1016/0022-1759(86)90079-7
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR, Blood, vol.119, issue.24, pp.5697-5705, 2012. ,
DOI : 10.1182/blood-2012-01-405365
Safety, Activity, and Immune Correlates of Anti???PD-1 Antibody in Cancer, New England Journal of Medicine, vol.366, issue.26, pp.2443-2454, 2012. ,
DOI : 10.1056/NEJMoa1200690
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape, Science Translational Medicine, vol.4, issue.127, pp.127-137, 2012. ,
DOI : 10.1126/scitranslmed.3003689
Immunology beats cancer: a blueprint for successful translation, Nature Immunology, vol.11, issue.12, pp.1129-1132, 2012. ,
DOI : 10.1038/nm730
Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms, European Journal of Immunology, vol.178, issue.10, pp.2977-2986, 2011. ,
DOI : 10.1002/eji.201141639
B7-DC-Ig Enhances Vaccine Effect by a Novel Mechanism Dependent on PD-1 Expression Level on T Cell Subsets, The Journal of Immunology, vol.189, issue.5, pp.2338-2347, 2012. ,
DOI : 10.4049/jimmunol.1103085
CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans, Clinical Cancer Research, vol.17, issue.12, pp.4101-4109, 2011. ,
DOI : 10.1158/1078-0432.CCR-11-0407
Tumor Dormancy, Oncogene Addiction, Cellular Senescence, and Self-Renewal Programs, Adv Exp Med Biol, vol.734, pp.91-107, 2013. ,
DOI : 10.1007/978-1-4614-1445-2_6
CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation, Cancer Cell, vol.18, issue.5, pp.485-498, 2010. ,
DOI : 10.1016/j.ccr.2010.10.002
Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions, The Journal of Immunology, vol.189, issue.12, pp.5493-5497, 2012. ,
DOI : 10.4049/jimmunol.1202065
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment, Current Opinion in Immunology, vol.25, issue.2, pp.952-791500193 ,
DOI : 10.1016/j.coi.2012.12.003
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts, Cancer Research, vol.70, issue.17, pp.6725-6734, 2010. ,
DOI : 10.1158/0008-5472.CAN-10-0735
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors, Journal of Clinical Investigation, vol.121, issue.12, pp.4746-4757, 2011. ,
DOI : 10.1172/JCI58814DS1
MFG-E8???mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF, Journal of Clinical Investigation, vol.117, issue.7, pp.1902-1913, 2007. ,
DOI : 10.1172/JCI30966DS1
Milk fat globule epidermal growth factor???8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms, The Journal of Experimental Medicine, vol.206, issue.6, pp.1317-1326, 2009. ,
DOI : 10.1073/pnas.90.8.3539
In situ regulation of CD subsets and T cells mediates tumor regression in mice, Sci Transl Med, vol.1, pp.8-19, 2009. ,
Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide???Based Vaccines, Journal of Clinical Oncology, vol.20, issue.11, pp.2624-2632, 2002. ,
DOI : 10.1200/JCO.2002.06.171
-Specific Vaccination in Patients With Metastatic Breast Cancer, Journal of Clinical Oncology, vol.27, issue.28, pp.4685-4692, 2009. ,
DOI : 10.1200/JCO.2008.20.6789
URL : https://hal.archives-ouvertes.fr/hal-01440327
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients, Clinical Cancer Research, vol.15, issue.6, pp.2148-2153, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1332
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival, Nature Medicine, vol.174, issue.8, pp.1254-1261, 2012. ,
DOI : 10.1016/j.cll.2007.05.002
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function, The Journal of Experimental Medicine, vol.79, issue.12, pp.2691-2702, 2006. ,
DOI : 10.1073/pnas.90.8.3539
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocytemacrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation, J Clin Oncol, vol.27, pp.5911-5918, 2009. ,
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer, British Journal of Cancer, vol.61, issue.10, pp.1712-1717, 2008. ,
DOI : 10.1158/1078-0432.CCR-08-0048
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer, New England Journal of Medicine, vol.353, issue.25, pp.2654-2666, 2005. ,
DOI : 10.1056/NEJMoa051424
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer, Cancer, vol.52, issue.3, pp.495-502, 2008. ,
DOI : 10.1002/cncr.23208
The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012. ,
DOI : 10.1038/nrc3245
The immunoscore as a new possible approach for the classification of cancer, J Transl Med, vol.3, pp.10-11, 2012. ,
Cancer classification using the Immunoscore: a worldwide task force, Journal of Translational Medicine, vol.10, issue.1, p.205, 2012. ,
DOI : 10.1186/1479-5876-10-1
URL : https://hal.archives-ouvertes.fr/inserm-00780742
Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy, Cancer Immunology, Immunotherapy, vol.24, issue.5, pp.685-691, 2008. ,
DOI : 10.1007/s00262-007-0407-z
A genetic inference on cancer immune responsiveness, OncoImmunology, vol.19, issue.4, pp.520-525 ,
DOI : 10.1007/s00262-007-0407-z